Abbott Laboratories said it plans to separate its nutrition business into an independent, publicly traded company ​and reduced its 2026 sales growth forecast, sending shares ‌down 3.4% in premarket trading.

Log in or sign up to comment.

No comments yet.

← Back to stories

Create FREE account

or login to continue

Signup with GoogleSignup with GitHubSignup with BlueskySignup with Blacksky
Sign up with email

Already have an account? Log in